Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20852 | 382 | 35.8 | 79% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AK TUMORIMMUNOL VAKZINE | Address | 15 | 88% | 2% | 7 |
2 | MALP 2 | Author keyword | 6 | 48% | 3% | 10 |
3 | N ELECTROPHILIC AMINATION | Author keyword | 6 | 100% | 1% | 4 |
4 | LIPOPEPTIDE | Author keyword | 5 | 12% | 11% | 41 |
5 | UMR 8525 | Address | 5 | 17% | 7% | 25 |
6 | LIPOPEPTIDES | Author keyword | 4 | 12% | 9% | 34 |
7 | HYDRAZINOPEPTIDES | Author keyword | 3 | 60% | 1% | 3 |
8 | ALPHA OXO ALDEHYDE | Author keyword | 2 | 67% | 1% | 2 |
9 | BPPCYSMPEG | Author keyword | 2 | 67% | 1% | 2 |
10 | OUTER MEMBRANE LIPOPROTEIN I | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MALP 2 | 6 | 48% | 3% | 10 | Search MALP+2 | Search MALP+2 |
2 | N ELECTROPHILIC AMINATION | 6 | 100% | 1% | 4 | Search N+ELECTROPHILIC+AMINATION | Search N+ELECTROPHILIC+AMINATION |
3 | LIPOPEPTIDE | 5 | 12% | 11% | 41 | Search LIPOPEPTIDE | Search LIPOPEPTIDE |
4 | LIPOPEPTIDES | 4 | 12% | 9% | 34 | Search LIPOPEPTIDES | Search LIPOPEPTIDES |
5 | HYDRAZINOPEPTIDES | 3 | 60% | 1% | 3 | Search HYDRAZINOPEPTIDES | Search HYDRAZINOPEPTIDES |
6 | ALPHA OXO ALDEHYDE | 2 | 67% | 1% | 2 | Search ALPHA+OXO+ALDEHYDE | Search ALPHA+OXO+ALDEHYDE |
7 | BPPCYSMPEG | 2 | 67% | 1% | 2 | Search BPPCYSMPEG | Search BPPCYSMPEG |
8 | OUTER MEMBRANE LIPOPROTEIN I | 2 | 67% | 1% | 2 | Search OUTER+MEMBRANE+LIPOPROTEIN+I | Search OUTER+MEMBRANE+LIPOPROTEIN+I |
9 | P3CSK4 | 2 | 67% | 1% | 2 | Search P3CSK4 | Search P3CSK4 |
10 | CHIRAL GLYCEROL DERIVATIVE | 1 | 100% | 1% | 2 | Search CHIRAL+GLYCEROL+DERIVATIVE | Search CHIRAL+GLYCEROL+DERIVATIVE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BACTERIAL LIPOPROTEIN | 32 | 60% | 9% | 35 |
2 | ESCHERICHIA COLI LIPOPROTEIN | 26 | 69% | 6% | 22 |
3 | SYNTHETIC LIPOPEPTIDE | 11 | 65% | 3% | 11 |
4 | MALP 2 | 9 | 67% | 2% | 8 |
5 | TYPE 1 LIPOPEPTIDE VACCINE | 7 | 64% | 2% | 7 |
6 | MYCOPLASMA FERMENTANS | 5 | 25% | 5% | 18 |
7 | ALPHA OXO ALDEHYDES | 4 | 50% | 2% | 6 |
8 | MACROPHAGE ACTIVATING LIPOPEPTIDE 2 | 4 | 46% | 2% | 6 |
9 | LIVE VIRAL VECTORS | 2 | 67% | 1% | 2 |
10 | LIPOPEPTIDE ADJUVANTS | 2 | 50% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Self-adjuvanting lipopeptide vaccines | 2008 | 41 | 123 | 27% |
Recent advances with TLR2-Targeting lipopeptide-based Vaccines | 2007 | 17 | 67 | 46% |
Lipopeptide vaccines - yesterday, today, and tomorrow | 2002 | 118 | 58 | 33% |
Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations | 2001 | 17 | 38 | 63% |
Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact | 2015 | 1 | 109 | 24% |
Modern Subunit Vaccines: Development, Components, and Research Opportunities | 2013 | 31 | 219 | 12% |
alpha-Oxo Aldehyde or Glyoxylyl Group Chemistry in Peptide Bioconjugation | 2013 | 13 | 208 | 20% |
Triggering TLR signaling in vaccination | 2006 | 198 | 79 | 8% |
Toll-like receptor ligands energize peptide vaccines through multiple paths | 2007 | 32 | 18 | 11% |
From fundamental immunology to development of vaccinology | 2008 | 1 | 27 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AK TUMORIMMUNOL VAKZINE | 15 | 88% | 1.8% | 7 |
2 | UMR 8525 | 5 | 17% | 6.5% | 25 |
3 | UMR 8525 BIOL LILLE | 2 | 67% | 0.5% | 2 |
4 | U445 | 1 | 17% | 1.8% | 7 |
5 | DPT ISEN | 1 | 40% | 0.5% | 2 |
6 | CHIM MOL ORGANIZAT SOLIDE | 1 | 50% | 0.3% | 1 |
7 | CNRS PHARMUMR 7175 | 1 | 50% | 0.3% | 1 |
8 | EPI 99 08 | 1 | 50% | 0.3% | 1 |
9 | EPI 9908 | 1 | 50% | 0.3% | 1 |
10 | GALENCIO | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000293774 | PEPTIDE PROT CHEM//PHYSICOCHEM UNIT//QUIM PEPTIDS PROT |
2 | 0.0000114060 | CLORICROMENE//LIPIDIC AMINO ACID//LIPOAMINO ACIDS |
3 | 0.0000088460 | MD 2//CD14//LIPOPOLYSACCHARIDE BINDING PROTEIN |
4 | 0.0000083321 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
5 | 0.0000078710 | PORINS//IMMUNOL VACCINE DEV//ITY LOCUS |
6 | 0.0000076279 | ISCOMS//ISCOM//QUIL A |
7 | 0.0000072249 | LPS HYPERSENSITIVITY//CORYNEBACTERIUM PARVUM//NCPP |
8 | 0.0000065546 | TUMOR VACCINOL//GLYCOPEPTIDES//CARL S MARVEL S |
9 | 0.0000060223 | FRONTIER SCI INNOVAT//LAYER EXPANSION//MOLECULAR BRIDGING |
10 | 0.0000059478 | TOLL LIKE RECEPTOR 9//TOLL LIKE RECEPTOR 3//95D CELL |